Stockreport

France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF Updated national AAC protocol supports hospital-based, fully-reimbursed compassionate access across three solid tumor settings LEXINGTON, Mass.--(BUSINESS WIRE)--Agen [Read more]